UMMS Affiliation

Department of Pathology; Graduate School of Biomedical Sciences, Program in Immunology and Microbiology

Publication Date

4-11-2016

Document Type

Article

Disciplines

Immunology of Infectious Disease | Immunopathology | Immunoprophylaxis and Therapy | Influenza Virus Vaccines | Virology | Virus Diseases

Abstract

Influenza viral evolution presents a formidable challenge to vaccination due to the virus' ability to rapidly mutate to evade immune responses. Live influenza infections generate large and diverse CD4 effector T cell responses that yield highly protective, long-lasting CD4 T cell memory that can target conserved viral epitopes. We review advances in our understanding of mechanisms involved in generating CD4 T cell responses against the influenza A virus (IAV), focusing on specialized follicular helper (TFH) and CD4 cytotoxic (ThCTL) effector subsets and on CD4 T cell memory. We also discuss two recent findings in context of enhancing vaccine responses. First, helper T cells require priming with APC secreting high levels of IL-6. Second, the transition of IAV-generated effectors to memory depends on IL-2, costimulation and antigen signals, just before effectors reach peak numbers, defined as the "memory checkpoint." The need for these signals during the checkpoint could explain why many current influenza vaccines are poorly effective and elicit poor cellular immunity. We suggest that CD4 memory generation can be enhanced by re-vaccinating at this time. Our best hope lies in a universal vaccine that will not need to be formulated yearly against seasonal antigenically novel influenza strains and will also be protective against a pandemic strain. We suggest a vaccine approach that elicits a powerful T cell response, by initially inducing high levels of APC activation and later providing antigen at the memory checkpoint, may take us a step closer to such a universal influenza vaccine.

Rights and Permissions

Citation: Front Immunol. 2016 Apr 11;7:136. doi: 10.3389/fimmu.2016.00136. eCollection 2016. Link to article on publisher's site

DOI of Published Version

10.3389/fimmu.2016.00136

Related Resources

Link to Article in PubMed

Keywords

CD4 T cells, cell-mediated immunity, influenza, late-antigen, memory checkpoint, vaccination

Journal/Book/Conference Title

Frontiers in immunology

PubMed ID

27148257

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.